Pharmaceutical groups have raised concerns that FDA’s draft social media guidance are not practical and could discourage pharmaceutical companies from interacting with consumers via social media, The Hill reports (Devaney, The Hill, 9/23).

Background on FDA’s Draft Guidance

In June, FDA issued draft guidance outlining how drugmakers and medical device makers should highlight the benefits and risks of their products via social media and how they should address and correct misinformation regarding their products posted by third parties.

The draft guidance would require drug and medical device manufacturers to disclose the benefits and potential risks of their products when posting about the items on social media, even if the social media platform only offers limited character space.

via Pharma Companies Urge FDA To Alter Draft Social Media Rules – iHealthBeat.

Recommended Posts